These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 24958099
1. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Meakin PJ, Chowdhry S, Sharma RS, Ashford FB, Walsh SV, McCrimmon RJ, Dinkova-Kostova AT, Dillon JF, Hayes JD, Ashford ML. Mol Cell Biol; 2014 Sep; 34(17):3305-20. PubMed ID: 24958099 [Abstract] [Full Text] [Related]
2. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). Sharma RS, Harrison DJ, Kisielewski D, Cassidy DM, McNeilly AD, Gallagher JR, Walsh SV, Honda T, McCrimmon RJ, Dinkova-Kostova AT, Ashford MLJ, Dillon JF, Hayes JD. Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625 [Abstract] [Full Text] [Related]
3. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet. Li J, Sapper TN, Mah E, Rudraiah S, Schill KE, Chitchumroonchokchai C, Moller MV, McDonald JD, Rohrer PR, Manautou JE, Bruno RS. Mol Nutr Food Res; 2016 Apr; 60(4):858-70. PubMed ID: 26679056 [Abstract] [Full Text] [Related]
4. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet. Liu X, Henkel AS, LeCuyer BE, Schipma MJ, Anderson KA, Green RM. Am J Physiol Gastrointest Liver Physiol; 2015 Dec 15; 309(12):G965-74. PubMed ID: 26472223 [Abstract] [Full Text] [Related]
5. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2. Bathish B, Robertson H, Dillon JF, Dinkova-Kostova AT, Hayes JD. Free Radic Biol Med; 2022 Aug 01; 188():221-261. PubMed ID: 35728768 [Abstract] [Full Text] [Related]
6. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice. Vida M, Gavito AL, Pavón FJ, Bautista D, Serrano A, Suarez J, Arrabal S, Decara J, Romero-Cuevas M, Rodríguez de Fonseca F, Baixeras E. Dis Model Mech; 2015 Jul 01; 8(7):721-31. PubMed ID: 26035386 [Abstract] [Full Text] [Related]
7. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Lee DH, Han DH, Nam KT, Park JS, Kim SH, Lee M, Kim G, Min BS, Cha BS, Lee YS, Sung SH, Jeong H, Ji HW, Lee MJ, Lee JS, Lee HY, Chun Y, Kim J, Komatsu M, Lee YH, Bae SH. Free Radic Biol Med; 2016 Oct 01; 99():520-532. PubMed ID: 27634173 [Abstract] [Full Text] [Related]
8. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFκB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice. Ding X, Jian T, Li J, Lv H, Tong B, Li J, Meng X, Ren B, Chen J. Oxid Med Cell Longev; 2020 Oct 01; 2020():9734560. PubMed ID: 33204402 [Abstract] [Full Text] [Related]
9. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet. Liu Z, Dou W, Ni Z, Wen Q, Zhang R, Qin M, Wang X, Tang H, Cao Y, Wang J, Zhao S. Mol Med Rep; 2016 Aug 01; 14(2):1323-31. PubMed ID: 27315552 [Abstract] [Full Text] [Related]
10. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation. Cui Y, Wang Q, Li X, Zhang X. Redox Biol; 2013 Aug 01; 1(1):433-40. PubMed ID: 24191237 [Abstract] [Full Text] [Related]
11. Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice. Lee LY, Köhler UA, Zhang L, Roenneburg D, Werner S, Johnson JA, Foley DP. Toxicol Sci; 2014 Dec 01; 142(2):361-74. PubMed ID: 25294219 [Abstract] [Full Text] [Related]
12. Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK/ACC in high-fat diet-fed mice. Kawaguchi T, Ueno T, Nogata Y, Hayakawa M, Koga H, Torimura T. Int J Mol Med; 2017 Feb 01; 39(2):407-414. PubMed ID: 28000843 [Abstract] [Full Text] [Related]
13. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway. Huang B, Xiong X, Zhang L, Liu X, Wang Y, Gong X, Sang Q, Lu Y, Qu H, Zheng H, Zheng Y. J Mol Cell Biol; 2021 Oct 21; 13(7):527-539. PubMed ID: 34048566 [Abstract] [Full Text] [Related]
14. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M. J Hepatol; 2014 May 21; 60(5):1017-25. PubMed ID: 24362075 [Abstract] [Full Text] [Related]
15. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice. Dusabimana T, Park EJ, Je J, Jeong K, Yun SP, Kim HJ, Kim H, Park SW. Int J Mol Sci; 2021 May 24; 22(11):. PubMed ID: 34073834 [Abstract] [Full Text] [Related]
16. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Wei G, An P, Vaid KA, Nasser I, Huang P, Tan L, Zhao S, Schuppan D, Popov YV. Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G174-G188. PubMed ID: 31630534 [Abstract] [Full Text] [Related]
17. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet. Wang C, Cui Y, Li C, Zhang Y, Xu S, Li X, Li H, Zhang X. Lipids Health Dis; 2013 Nov 04; 12():165. PubMed ID: 24188280 [Abstract] [Full Text] [Related]
18. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling. Liang L, Ye S, Jiang R, Zhou X, Zhou J, Meng S. Int Immunopharmacol; 2022 Mar 04; 104():108306. PubMed ID: 34999396 [Abstract] [Full Text] [Related]
19. Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet. Okada K, Warabi E, Sugimoto H, Horie M, Gotoh N, Tokushige K, Hashimoto E, Utsunomiya H, Takahashi H, Ishii T, Yamamoto M, Shoda J. J Gastroenterol; 2013 May 04; 48(5):620-32. PubMed ID: 22972520 [Abstract] [Full Text] [Related]
20. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. Orlicky DJ, Libby AE, Bales ES, McMahan RH, Monks J, La Rosa FG, McManaman JL. J Physiol; 2019 Mar 04; 597(6):1565-1584. PubMed ID: 30536914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]